Utah Medical Products (UTMD)
(Delayed Data from NSDQ)
$67.91 USD
+0.68 (1.01%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $67.78 -0.13 (-0.19%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
UTMD 67.91 +0.68(1.01%)
Will UTMD be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for UTMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for UTMD
Utah Medical Q3 Earnings Decline Y/Y on Lower OEM Sales
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
UTMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top Analyst Reports for Linde, AstraZeneca & Walt Disney
Utah Medical (UTMD) Q2 EPS Falls Y/Y on Lower Key Customer Sales
Zacks Initiates Coverage of UTMD With Neutral Recommendation
Other News for UTMD
Dividend Champion, Contender, And Challenger Highlights: Week Of November 10
Utah Medical Products raises dividend by 1.75 to $0.305
Utah Medical Products appoints Carrie Leigh to board of directors
Utah Medical board raises quarterly cash dividend by 1.7% to 30.5c per share
Utah Medical Products appoints Carrie Leigh to board of directors